TriangleDISEASE & TREATMENT SETTING
Pancreatic Cancer
Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.
Exact scope
Pancreatic Cancer
- Source population
- Not part of this definition
- Disease extent
- Not part of this definition
- Treatment line
- Not part of this definition
- Stage
- Not part of this definition
- Resectability
- Not part of this definition
Biomarkers, prior therapy and derivation
- molecular
- prior therapy
- derivation status
- unresolved
- derivation note
- Derived from NCI topic(s): Pancreatic Cancer. Strongest NCIt resolution: ambiguous. Entity-level scope; stage, biomarker and treatment line are not yet part of this definition.
- source wording
- Source null
7 more-specific settings
Study evidence for this setting
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
Bupropion in Helping Adults Stop Smoking
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Acceptability of Less Harmful Alternatives to Cigarettes
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Tr
Cancer in Patients With Gabapentin (GPRD)
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
Source relationships and population-mapping limitations
- bindings
- release id
- clinical-indications-draft-1
- disease state id
- ds-pancreatic-cancer
- binding id
- ncit-C207229
- source collection
- ncit-concept
- source key
- C207229
- source excerpt
- Source null
- match status
- ambiguous
- match note
- Resolution status: ambiguous.
- recorded at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-pancreatic-cancer
- binding id
- ncit-C9005
- source collection
- ncit-concept
- source key
- C9005
- source excerpt
- Source null
- match status
- ambiguous
- match note
- Resolution status: ambiguous.
- recorded at
- 2026-09-10T00:00:00Z
- mappings
Download this complete draft source relationship record →
Preserved source evidence · Not medical advice